New 52 Week High Today

Halozyme Therapeutics Inc HALO:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 6:05 PM EDT
43.82UNCH (UNCH)
Volume
42,896
Close
43.82quote price arrow up+0.21 (+0.48%)
Volume
1,058,889
52 week range
31.86 - 45.18
Loading...
  • Open44.03
  • Day High45.18
  • Day Low43.55
  • Prev Close43.61
  • 52 Week High45.18
  • 52 Week High Date05/14/24
  • 52 Week Low31.86
  • 52 Week Low Date06/01/23

Key Stats

  • Market Cap5.568B
  • Shares Out127.05M
  • 10 Day Average Volume1.15M
  • Dividend-
  • Dividend Yield-
  • Beta1.27
  • YTD % Change18.56

KEY STATS

  • Open44.03
  • Day High45.18
  • Day Low43.55
  • Prev Close43.61
  • 52 Week High45.18
  • 52 Week High Date05/14/24
  • 52 Week Low31.86
  • 52 Week Low Date06/01/23
  • Market Cap5.568B
  • Shares Out127.05M
  • 10 Day Average Volume1.15M
  • Dividend-
  • Dividend Yield-
  • Beta1.27
  • YTD % Change18.56

RATIOS/PROFITABILITY

  • EPS (TTM)2.42
  • P/E (TTM)18.13
  • Fwd P/E (NTM)11.96
  • EBITDA (TTM)463.919M
  • ROE (TTM)261.68%
  • Revenue (TTM)862.989M
  • Gross Margin (TTM)78.50%
  • Net Margin (TTM)36.94%
  • Debt To Equity (MRQ)844.10%

EVENTS

  • Earnings Date08/06/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Halozyme Therapeutics Inc

 

Profile

MORE
Halozyme Therapeutics, Inc. is a biopharmaceutical company advancing disruptive solutions to improve patient experiences and outcomes for emerging and established therapies. The Company’s ENHANZE drug delivery technology with the proprietary enzyme rHuPH20, its commercially validated solution is used to facilitate the subcutaneous (SC) delivery of injected drugs and fluids, with a focus on reducing treatment burden for patients. It also develops, manufactures, and...
Jeffrey Henderson
Independent Chairman of the Board
Helen Torley
President, Chief Executive Officer, Director
Nicole Labrosse
Chief Financial Officer, Senior Vice President
Address
12390 EL CAMINO REAL
San Diego, CA
92130
United States

Top Peers

SYMBOLLASTCHG%CHG
APLS
Apellis Pharmaceuticals Inc
41.20-1.81-4.21%
ITCI
Intra-Cellular Therapies Inc
65.71-0.61-0.92%
BBIO
BridgeBio Pharma Inc
28.95+0.45+1.58%
ACAD
ACADIA Pharmaceuticals Inc
14.86-0.32-2.11%
PTCT
PTC Therapeutics Inc
31.18-0.52-1.64%